This page contains recent news articles, when available, and an overview of but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Background information on

Pemphigus Vulgaris, Type of Bullous Diseases-Skin Disorders  -  Feb 27, 2008
Best Syndication,The bullae of pemphigus vulgaris arise from normal-appearing skin, there is essentially no surrounding inflammation. The blisters are also extraordinarily

Two Kansas U. students will cycle coast to coast for a cause  -  Mar 23, 2008
St. Louis Post-Dispatch,...his mother was diagnosed with pemphigus vulgaris, a rare autoimmune skin disorder two years ago; his teenage cousin is fighting an unidentifiable

Peptimmune, Inc. Renews 4335-Square-Foot Sublease at 64 Sidney ...  -  Mar 5, 2008
Boston/SF,...with second-generation therapeutics that are expected to result in safer and more effective products for multiple sclerosis and pemphigus vulgaris.

genital herpes  -  Feb 12, 2008
Pulse,These include Behcetâ€™s syndrome, eczema, pemphigus vulgaris and lichen sclerosus. If the infection is severe enough to treat, prescribe a five-day course of

Wendy Ann Satmary, MD, Kaiser Permanente Medical Center, Woodland ...  -  Jan 30, 2008
AAFP News Now...mucous membrane pemphigoid, pemphigus vulgaris, BehÃ§et's syndrome, desquamative inflammatory vaginitis, lichenoid drug reactions, and graft-versus-host

Pemphigus Vulgari Facts and Treatment  -  Dec 15, 2007
American Chronicle,Pemphigus vulgaris is an autoimmune skin disorder characterized by blistering of the skin and mucous membrane. Pemphigus is an autoimmune disorder that

Lymphoma drug used to treat skin disorders  -  Dec 15, 2007
Hindu,...treated patients with various kinds of blistering skin disease, including pemphigus vulgaris, dermatomyositis, and paraneoplastic pemphigus.

Center for Clinical and Translational Science funds eight new ...  -  Dec 21, 2007
The Rockefeller University Newswire,Mouquet Hugo, postdoctoral fellow in Michel Nussenzweigâ€™s Laboratory of Molecular Immunology, to elucidate the etiology of Pemphigus vulgaris,

aspreva pharmaceuticals announces results for third quarter 2007  -  Oct 31, 2007
CNNMoney.com...in addition to the ongoing activities in the maintenance phase of the lupus nephritis trial and the pemphigus vulgaris trial. as in previous quarters,

mass. doc pleads guilty in medicare case  -  Nov 5, 2007
The Associated Press...which cost between $10000 and $12000 per month. the treatments are used for a severe, life-threatening skin disease called pemphigus vulgaris,

around the nation  -  Nov 5, 2007
Arizona Daily Star,...persuading medicare to cover the costs of expensive, intravenous treatments for patients with pemphigus vulgaris, a rare, potentially fatal skin disease.

dermatologist pleads guilty to obstruction, surrenders $2.9m  -  Nov 5, 2007
Boston Herald,...life-threatening skin disease called pemphigus vulgaris with samples from patients with pemphigoid, a less-serious disease. yet to his patients,

premium company profile aspreva pharmaceuticals corporation  -  Nov 2, 2007
Pharmaceutical Business Review...multiple sclerosis, pemphigus vulgaris, and scleroderma/systemic sclerosis. cellcept is under various stages of drug development process for the above

doc to surrender $2.9m in medicare case  -  Nov 5, 2007
The Associated Press...single-handedly persuading medicare to cover the costs of expensive, intravenous immunoglobulin treatments for patients with pemphigus vulgaris, a rare,

Aspreva sells for $915 million  -  19 Oct 2007
Canada.com,...signed a licensing agreement with Roche to use CellCept in trials to treat less-common autoimmune diseases such lupus nephritis and pemphigus vulgaris.

Advances In The Science Of Wounding Healing And Care  -  Oct 17, 2007
Medical News Today,Robert S. Kirsner, MD, Ph.D., University of Miami, explains "Medical conditions as diverse as pemphigus vulgaris, primary syphilis, lupus erythematosus and

Editorial: Dermatologists advance science of wound healing, care  -  Oct 15, 2007
EurekAlert (press release),...â€œMedical conditions as diverse as pemphigus vulgaris, primary syphilis, lupus erythematosus and sarcoidosis all either have or can have wounds as part of

Peptimmune Initiates Phase I Study With a Novel Peptide Copolymer ...  -  Oct 3, 2007
PR Newswire (press release),...with second-generation therapeutics that are expected to result in safer and more effective products for multiple sclerosis and pemphigus vulgaris.

Aspreva and Roche Update CellCept Agreement  -  Aug 29, 2007
PharmaLive.com (press release),...of CellCept in autoimmune indications; and our two phase III clinical programs underway with CellCept: lupus nephritis and pemphigus vulgaris.

Can the Ravages of Dementia in HIV/AIDS Be Arrested?  -  Aug 16, 2007
Scientific American...arthritis and a skin disease called pemphigus vulgaris, a blistering disorder of the skin and mucous membranes that can lead to a slow, painful death.

Autoimmune Disease Yields to Single Rituximab Cycle  -  Aug 8, 2007
MedPage Today,..."Its use must be restricted to a limited number of patients with pemphigus vulgaris or pemphigus foliaceus that is not responsive to conventional therapy

Aspreva Pharmaceuticals Announces Results for Second Quarter 2007  -  Jul 31, 2007
Earthtimes.orgThe maintenance phase of the lupus trial also progressed through the quarter, as did the pemphigus vulgaris trial, which reached full enrollment during the

Aspreva announces restructuring designed to drive long-term growth  -  Jul 25, 2007
CNNMoney.comAspreva remains committed to the partnership with Roche and to the patients participating in the ongoing lupus nephritis and pemphigus vulgaris studies.

CORRECTION: Watts Water Technologies Q2 Profit Declines; Declares ...  -  Jul 31, 2007
RTT News,Aspreva indicated having two phase III clinical programs currently underway with CellCept, lupus nephritis and pemphigus vulgaris.

Cleveland-Cliffs Reveals Closing Of PinnOak Resources Acquisition ...  -  Jul 31, 2007
RTT News,The company expect to complete our 52-week pemphigus vulgaris trial in 2008. 7/31/2007 5:41:33 PM BRE Properties, Inc. (BRE) on Tuesday posted second

Aspreva Pharmaceuticals: New uses for established drugs  -  Jul 18, 2007
Blogging Stocks...the use of Hoffmann-La Roche's organ transplant drug CellCept in treating such autoimmune diseases as lupus nephritis and pemphigus vulgaris.

Aspreva and Roche announce preliminary results for phase III study ...  -  Jun 27, 2007
Canada NewsWire (press release),...of CellCept in autoimmune indications; and our two phase III clinical programs underway with CellCept: lupus nephritis and pemphigus vulgaris.

2nd Phase III CellCept Failure Sends Aspreva Shares Down  -  Jun 27, 2007
BioWorld Online,...to two additional licensing deals in 2007. Data from an ongoing Phase III trial in the autoimmune skin disease pemphigus vulgaris are expected next year.

Oral pemphigus vulgaris  -  Apr 20, 2007
RDH,A review of his health history suggests that he has been diagnosed with pemphigus vulgaris during the past six months. You quickly retrieve all the

Regulatory T Cells Are Severely Reduced In Pemphigus Vulgaris  -  Apr 9, 2007
Medical News Today (press release),...shows that a severe reduction of T (Treg) cells may be involved in the pathogenesis of pemphigus vulgaris (PV), an autoimmune blistering disease.

Sunny revenue outlook boosts Aspreva stock  -  Apr 20, 2007
Vancouver Sun (subscription),...developed for heart, liver and kidney transplant patients,to Phase 3 clinical trials for both autoimmune indications lupus nephritis and pemphigus vulgaris.

Aspreva Pharmaceuticals Reports 2006 Fourth Quarter and Year End ...  -  Feb 7, 2007
Earthtimes.orgReceived orphan drug designation from the US Food and Drug Administration (FDA) for CellCept in the treatment of pemphigus vulgaris.

Peptimmune to Provide a Progress Report on the Company's Clinical ...  -  Feb 9, 2007
PR Newswire (press release),...that are expected to result in safer and more effective therapies for multiple sclerosis, pemphigus vulgaris, rheumatoid arthritis and obesity.

Aspreva Pharmaceuticals Reports 2006 Fourth Quarter and Year End ...  -  Feb 12, 2007
Drug Newswire (press release),...continued build out of the global business, and preparation for the potential commercialization of CellCept in lupus nephritis and pemphigus vulgaris.

Talecris Biotherapeutics Names Inaugural Talents Grant Recipients  -  Jan 5, 2007
Carolina Newswire (press release),...placebo controlled trial to assess the safety and efficacy of intravenous immunoglobulin in the treatment of pemphigus vulgaris.â€?

Unusual thrombotic cardiac complications of Pemphigus vulgaris: a ...  -  Dec 23, 2006
HeartZine,We are reporting a case of Pemphigus vulgaris with extensive thrombosis of deep veins, pulmonary veins, and cardiac chambers complicated by myocardial

Peptimmune, Orphan Europe to develop immunotherapy for life ...  -  Dec 7, 2006
Therapeutics Daily (subscription) (press release),Pemphigus vulgaris is characterized by blistering of the skin and the mucous membranes, and the patient will suffer progressive skin loss until sepsis

Southwest Hispanics find links to crypto-Judaism  -  Dec 23, 2006
Pueblo Chieftain,Pemphigus Vulgaris, for example, is a rare dermatological disease that strikes Jewish people in greater numbers than the general population.

Peptimmune, Orphan Europe to develop immunotherapy for life ...  -  Dec 7, 2006
Therapeutics Daily (subscription) (press release),Europe have signed a Scientific Collaboration and License Agreement regarding the development of a peptide immunotherapy for the treatment of pemphigus vulgaris ...

Researchers target multiple sclerosis  -  Nov 22, 2006
Science Daily (press release)Carolina at Chapel Hill may have found a safer, more effective way to treat the life-threatening autoimmune skin disease pemphigus vulgaris without turning off ...

Search the web for more resources on

Web health.mongabay.com

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.